ANDREINA NEALL: Open Payments
NPI 1740931088 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,828 in 163 payments from 32 companies in 2025. Trend: 2023 $5,394 · 2024 $4,895 · 2025 $2,828
Food & beverage: $2,678Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 19 | $622 |
| EMD Serono, Inc. | 5 | $206 |
| Amgen Inc. | 10 | $205 |
| TG Therapeutics, Inc. | 8 | $189 |
| ABBVIE INC. | 10 | $168 |
| Genentech USA, Inc. | 13 | $162 |
| Novartis Pharmaceuticals Corporation | 33 | $141 |
| Vanda Pharmaceuticals Inc. | 12 | $139 |
| Celgene Corporation | 15 | $135 |
| UCB, Inc. | 5 | $116 |
Products named: TYSABRI, UPLIZNA, BRIUMVI, KESIMPTA, PONVORY, ZEPOSIA, Ocrevus Zunovo, VUMERITY.
Industry payments across FL — which companies pay providers there.
